Patent ID: 9642874
Date: 2017-05-09
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method of replacing insulin in a subject comprising: administering a composition to the subject, the composition comprising at least three different compounds selected from the group consisting of 5′-Methylselenoadenosine, Se-Adenosyl-L-homocysteine, Gamma-glutamyl-methylseleno-cysteine, a compound of Formula (I), a compound of Formula (II), and a compound of Formula (III); and a carrier, wherein the composition contains at least about 0.033% (w/v) of each of the at least three different compounds that is selected, wherein Formula (I) is: or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, wherein R R R R R R R R wherein Formula (II) is: or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, wherein R R R R R R R R R R wherein Formula (III) is: or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, wherein R R R R R R R